Top-News
Professionelle Dienstleistungen Schweden

IRLAB Therapeutics AB A News

Aktie
WKN:  A2PLBE ISIN:  SE0012675361
1,33 €
-0,03 €
-2,21%
16.05.24 08:02:22
Handeln Depot/Watchlist
Aktienanzahl *
-
Marktkapitalisierung *
-
Streubesitz
-
Index-Zugehörigkeit
-

IRLAB Therapeutics AB A News

13.09.22 - ACCESSWIRE
IRLAB to Present at ABGSC Investor Day on September 13, 2022
GOTHENBURG, SWEDEN / ACCESSWIRE / September 13, 2022 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a clinical-...
12.09.22 - ACCESSWIRE
IRLAB Completes Recruitment in Phase IIb Study of Mesdopetam (IRL790) in Patients with Parkinson's Levodopa-Induced Dyskinesias
GOTHENBURG, SWEDEN / ACCESSWIRE / September 12, 2022 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) IRLAB (Nasdaq Stockholm:IRLAB A), a clinical-​stage ...
07.09.22 - ACCESSWIRE
IRLAB to Present at Pareto Securities’ 13th Annual Healthcare Conference
GOTHENBURG, SE / ACCESSWIRE / September 07, 2022 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA) Gothenburg, Sweden, September 7, 2022 - IRLAB Therapeutics AB ...
06.09.22 - ACCESSWIRE
IRLAB's partner Ipsen Initiates Clinical Studies in Line with Mesdopetam's Development Plan
GOTHENBURG, SWEDEN / ACCESSWIRE / September 6, 2022 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, September 6, 2022 - IRLAB Therapeutics AB ...
31.08.22 - ACCESSWIRE
IRLAB Assists Swedish Economic Crime Authority
GOTHENBURG, SE / ACCESSWIRE / August 31, 2022 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA) On the 31 of August, 2022, IRLAB was contacted by the Swedish Economic ...
24.08.22 - ACCESSWIRE
IRLAB Publishes Interim Report for the Period January–June 2022
GOTHENBURG, SE / ACCESSWIRE / August 24, 2022 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA)
15.08.22 - ACCESSWIRE
IRLAB: Invitation to the Second Quarter and Half-year 2022 Results Presentation and Webcast
GOTHENBURG, SE / ACCESSWIRE / August 15, 2022 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA)
01.08.22 - ACCESSWIRE
Changed Number of Shares and Votes in IRLAB Therapeutics AB
GOTHENBURG, SE / ACCESSWIRE / August 01, 2022 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA)
11.07.22 - ACCESSWIRE
IRLAB Expands Phase IIb/III PD-LIDs Study with Mesdopetam to Support Phase III Program and Expects Completion of Enrollment During the Summer
GOTHENBURG, SWEDEN / ACCESSWIRE / July 11, 2022 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA)
09.06.22 - ACCESSWIRE
IRLAB Strengthens Its Management Team by Appointing Richard Godfrey as New CEO and Nicholas Waters as Executive Vice President and Head of R&D
GOTHENBURG, SE / ACCESSWIRE / June 9, 2022 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA) IRLAB (Nasdaq Stockholm:IRLAB A) announced today that additional expertise ...
11.05.22 - ACCESSWIRE
Report from the Annual General Meeting of IRLAB Therapeutics AB
GOTHENBURG, SWEDEN / ACCESSWIRE / May 11, 2022 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA)
11.05.22 - ACCESSWIRE
IRLAB Interim Report January – March, 2022
GOTHENBURG, SE / ACCESSWIRE / May 11, 2022 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA)
31.12.21 - ACCESSWIRE
Board Member Leaves IRLAB for Another Assignment
GOTHENBURG, SE / ACCESSWIRE / December 31, 2021 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA)
22.12.21 - ACCESSWIRE
IRLAB Obtains Regulatory Approval to Conduct Phase IIb Study With Pirepemat – One Step Closer To Improving Balance and Reducing Fall Injuries For People Living With Parkinson’s Disease
GOTHENBURG, SWEDEN / ACCESSWIRE / December 22, 2021 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA)
10.11.21 - ACCESSWIRE
IRLAB Publishes Interim Report for July 1 – September 30, 2021
GOTHENBURG, SWEDEN / ACCESSWIRE / November 10, 2021 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA)
05.11.21 - ACCESSWIRE
Nomination Committee in IRLAB Appointed Ahead of Annual General Meeting 2022
GOTHENBURG, SE / ACCESSWIRE / November 5, 2021 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA)
05.11.21 - ACCESSWIRE
Invitation to the Presentation of IRLAB´s Interim Report January – September 2021
GOTHENBURG, SE / ACCESSWIRE / November 5, 2021 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA)
03.06.21 - DGAP
IRLAB Therapeutics (IRLABA): Initiation - Focused on novel Parkinson's disease treatments
Edison Investment Research Limited IRLAB Therapeutics (IRLABA): Initiation - Focused on novel Parkinson's disease treatments 03-Jun-2021 / 08:12 GMT/BST London, UK, 3 ...
09.03.21 - PR Newswire
IRRAS Announces the recruitment of Sten Gustafsson as Director of Investor Relations
IRRAS Announces the recruitment of Sten Gustafsson as Director of Investor Relations PR Newswire
09.03.21 - PR Newswire
First European patients dosed in IRLAB's Phase IIb/III mesdopetam study
First European patients dosed in IRLAB's Phase IIb/III mesdopetam study PR Newswire

Newssuche

Videos

14.05.24 -2,24%
Technical Trading: DAX dienstags Long
DAX Long Typ: Turbo Open End WKN: NG8K9X Hebel: 26 Laufzeit: OpenEnd Einstieg: Market ... Mehr »